Share Information
| Listing | LSE |
| Ticker | IDHC |
| LSE Listing | May 2015 |
| ISIN Code | EGS99021C015 |
| Sector | Health Care & Pharmaceuticals |
| Par Value / Share | USD 0.25 |
| Number of Listed Shares | 581,326,272 |
| Issued Capital | USD 145,331,568 |
| Paid-In Capital | USD 145,331,568 |
Shareholding Structure
| % | |
| Free Float 50.38% | 50.38 |
| Actis IDH Ltd. 21.67% | 21.67 |
| Hena Holdings Ltd 27.94% | 27.94 |
As announced on 13 November 2025 by the Company, Actis GP LLP and Actis Guernsey GP Limited, each, a subsidiary of Actis LLP and which through funds under their management control shares representing 21.67% of the Company (the "Actis Shareholding"), have agreed to dispose, by way of an indirect share sale of Actis IDH Limited, of the entire Actis Shareholding to a special purpose vehicle, the majority of which is controlled by funds managed by Elliott Investment Management L.P. (the "Transaction"), of whom the ultimate beneficial owner is Paul Singer.
The Transaction was conditional on the receipt of regulatory clearance, which was received on 31 March 2026, at which point the transfer became unconditional, and was completed on Thursday 9 April 2026.
LSE SHARE PRICE
0.65USD
Last Close Price
0.83USD
52-Week High
0.32USD
52-Week Low
377.86USD
Market Cap (USD mn)
Historical Share Price Chart
* On 23 December 2020, IDH held an Extraordinary General Meeting where shareholders decided to undertake a subdivision of the Company's issued share capital, pursuant to which each Share was subdivided into four Shares. The subdivision was intended to bring the trading price of the Shares more in line with typical trading prices on the EGX in preparation for the Company's dual listing.